Free shipping on all orders over $ 500

 About 2 results found for searched term "PF-06835919" (0.139 seconds)

Cat.No.  Name Target
M21287 PF-06835919 Ketohexokinase
PF-06835919 is an oral Class I clinical candidate for NAFLD/NASH, targeting ketohexokinase (KHK), an enzyme that initiates fructose metabolism.
M49874 PF-06835919 Others
PF-06835919



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.